A Retrospective Cohort Study of Patients Who Underwent Curative-intent Esophagectomy for ESCC at a Tertiary Referral Center in South Korea
NCT ID: NCT07201571
Last Updated: 2025-10-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
3131 participants
OBSERVATIONAL
1994-11-06
2025-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Role of Esophagectomy in Complete Responders to CCRT
NCT01740375
Surgery Versus Non-surgical Treatment for Esophageal Squamous Cell Carcinoma in Patients Older Than 70 Years
NCT05604950
Textbook Outcomes After Oesophagectomy in Regional Australia
NCT06721715
A Clinical Trial of Esophagectomy for Esophageal Carcinoma
NCT06691503
Prognostic Factor Analysis in Metastatic Esophageal Squamous Cell Carcinoma
NCT01472419
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients who underwent curative surgery for esophageal cancer
Patients who underwent curative surgery for esophageal cancer
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* gastroesophageal junction cancer
* histology other than squamous cell carcinoma
* patients with Child-Pugh class B or C liver cirrhosis
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Samsung Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Seong Yong Park
Samsung Medical Center
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SMC-ESCC
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.